Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia

NCT00539266 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Intermittent Claudication
Peripheral Vascular Diseases

Interventions

BIOLOGICAL: bone marrow derived mononuclear cells
BIOLOGICAL: placebo

Sponsor

Leiden University Medical Center